Diagnostic HYBRIDS Announces Release of D3(R) Ultra(TM) DFA Respiratory Virus Screening and Identification Kit for Seven Major Respiratory Viruses.ATHENS, Ohio -- Diagnostic HYBRIDS announces the release of the D3[R] Ultra(TM) DFA DFA - Deterministic Finite-state Automaton. See Finite State Machine. Respiratory Virus Screening & Identification Kit. This second generation kit contains an increased number and better quality of antibodies for the detection of Influenza A, Influenza B, Parainfluenza parainfluenza Infectious disease A virus that causes URIs–up to 50% of croup and 10–15% of bronchiolitis, bronchitis, pneumonias in toddlers Clinical Rhinorrhea, cold-like Sx Risk factors Preschool children; by school age most children have been exposed 1, 2 and 3, Respiratory Syncytial Virus respiratory syncytial virus (sĭnsĭsh`əl): see cold, common. and Adenovirus adenovirus Any of a group of spheroidal viruses, made up of DNA wrapped in a protein coat, that cause sore throat and fever in humans, hepatitis in dogs, and several diseases in fowl, mice, cattle, pigs, and monkeys. . The new Ultra kit offers a significant improvement in detection of Influenza B, Parainfluenza 3 and Adenovirus with no increase in background effects or non-specific results because of the improved antibodies. The one-step direct detection kit allows users to identify and differentiate seven major respiratory viruses in a 15-minute direct stain process, and it can be used for direct specimen testing as well as culture confirmation. According to Steven Geimer, Vice President of Sales, Marketing & Service at Diagnostic HYBRIDS, "5% to 20% of the U.S. population gets the flu each year, with Influenza A and B being the two main types of influenza virus associated with the flu illness. RSV RSV respiratory syncytial virus; Rous sarcoma virus. RSV abbr. respiratory syncytial virus RSV 1 Respiratory syncytial virus, see there 2 Rous sarcoma virus, see there is the most common cause of pneumonia and other respiratory diseases in children under 1 year of age. The D3[R] Ultra(TM) DFA kit makes it easy and cost-effective to identify those patients with severe respiratory illness regardless of the infecting virus (Influenza A or B, RSV, Adenovirus, Parainfluenza 1, 2 or 3)." About Diagnostic HYBRIDS Diagnostic HYBRIDS develops and commercializes innovative and genetically engineered cell-based detection products for virus and autoimmune human diagnostic applications and for the pharmaceutical and biotechnology industry with an initial focus on pharmacology assays and products that measure drug clearance and anti-viral interventions with drugs and vaccines. The company is certified to ISO (1) See ISO speed. (2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI. 13485 standards and manufactures live continuous and primary cell cultures for clinical diagnostics and pharmacology assays from its headquarters in Athens, OH. Diagnostic HYBRIDS was named one of the 500 Fastest Growing Companies in America in 2004 and 2005 by Inc. Magazine. The company is a pillar member of Omeris, a statewide organization of bioscience companies accelerating the bioscience and healthcare economy in Ohio. For more information, please visit www.dhiusa.com. Note to Editors: The "3" in D3[R] Ultra(TM) DFA should be superscript Any letter, digit or symbol that appears above the line. For example, 10 to the 9th power is written with the 9 in superscript (109). Contrast with subscript. . |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion